Graph AI secures $3M seed round to enhance pharmacovigilance with AI
Graph AI raises $3M to build AI tools for drug safety monitoring and adverse reaction detection.
Live Market Updates
Latest Financial News
News Feed
1 articles
Personalized
Live Market Updates
Latest Financial News
positive
4 days agoGraph AI secures $3M seed round to enhance pharmacovigilance with AI
Graph AI, a U.S.-based healthcare tech startup focusing on drug safety, has raised $3 million in seed funding led by Bessemer Venture Partners. The startup develops AI models to automate detection and monitoring of adverse drug reactions, improving patient safety and regulatory reporting. The capital will go toward product development, data partnerships, and scaling its platform across global pharmaceutical clients. As regulatory scrutiny and compliance needs grow, Graph AI’s solution is positioned to support the AI-powered evolution of pharmacovigilance systems.
positive
4 days agoGraph AI secures $3M seed round to enhance pharmacovigilance with AI
Graph AI, a U.S.-based healthcare tech startup focusing on drug safety, has raised $3 million in seed funding led by Bessemer Venture Partners. The startup develops AI models to automate detection and monitoring of adverse drug reactions, improving patient safety and regulatory reporting. The capital will go toward product development, data partnerships, and scaling its platform across global pharmaceutical clients. As regulatory scrutiny and compliance needs grow, Graph AI’s solution is positioned to support the AI-powered evolution of pharmacovigilance systems.
positive
Graph AI secures $3M seed round to enhance pharmacovigilance with AI
4 days ago
1 min read
80 words
Graph AI raises $3M to build AI tools for drug safety monitoring and adverse reaction detection.
Graph AI, a U.S.-based healthcare tech startup focusing on drug safety, has raised $3 million in seed funding led by Bessemer Venture Partners. The startup develops AI models to automate detection and monitoring of adverse drug reactions, improving patient safety and regulatory reporting. The capital will go toward product development, data partnerships, and scaling its platform across global pharmaceutical clients. As regulatory scrutiny and compliance needs grow, Graph AI’s solution is positioned to support the AI-powered evolution of pharmacovigilance systems.
Graph AI, a U.S.-based healthcare tech startup focusing on drug safety, has raised $3 million in seed funding led by Bessemer Venture Partners. The startup develops AI models to automate detection and monitoring of adverse drug reactions, improving patient safety and regulatory reporting. The capital will go toward product development, data partnerships, and scaling its platform across global pharmaceutical clients. As regulatory scrutiny and compliance needs grow, Graph AI’s solution is positioned to support the AI-powered evolution of pharmacovigilance systems.
Companies:
Graph AI
Tags:
ai
healthtech
ai
healthtech
startup
pharma
funding
Source:
Oct 16, 2025 • 21:42 IST